Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus midazolam + fentanyl for awake fiberoptic intubation
IRCT20161220031487N9Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Dec 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in difficult intubation (DI) comparing Dexmedetomidine with Fentanyl + midazolam (2 arms). Primary endpoints: Hemodynamic status, Oxygen saturation and 2 more. Started Dec 2017; status: completed.
02
Drugs
dexmedetomidinemidazolamfentanyl
03
Conditions
difficult intubation (DI)
Beyond the preview
Go deeper on IRCT20161220031487N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20161220031487N9.